Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
07/24/2015 07/27/2015 07/28/2015 07/29/2015 07/30/2015 Date
11.22 11.08 11.38 11.75 11.75 Last
5430 1300 4050 11878 5751 Volume
-2.43% -1.25% +2.71% +3.25% 0.00% Change
Financials ( CAD)
Sales 2015 41,3 M
EBIT 2015 -14,1 M
Net income 2015 -8,74 M
Debt 2015 -
Yield 2015 -
Sales 2016 52,0 M
EBIT 2016 -10,7 M
Net income 2016 0,53 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 4,78x
Capi. / Sales 2016 3,80x
Capitalization 197 M
More Financials
Company
Cardiome Pharma Corp. is a specialty pharmaceutical company, which engages in the discovery, development and commercialization of cardiovascular therapies that will improve the health of patients suffering from heart disease.Cardiome has two marketed, in-hospital, cardiology products, BRINAVESS,... 
Sector
Pharmaceuticals
Calendar
08/10Earnings Release
More about the company
Surperformance© ratings of Cardiome Pharma Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on CARDIOME PHARMA CORP
07/29 CARDIOME PHARMA : Increases Bought Deal Financing to US$20.0 Million
07/29 TRICON CAPITAL : IIROC Trade Resumption - TCN, COM
07/29 IIROC Trade Resumption - Cardiome Pharma Corp.
07/28 CARDIOME PHARMA : Announces Approximately US$15.0 Million Bought Deal Financing
07/28 CARDIOME PHARMA : To Hold Second Quarter 2015 Results Conference Call on August ..
07/28 CARDIOME PHARMA : IIROC Trading Halt - COM
07/28 CARDIOME PHARMA : Announces Approximately US$15.0 Million Bought Deal Financing
07/28 IIROC Trade Halt - Cardiome Pharma Corp.
More news
Sector news : Biopharmaceuticals
01:13pDJABBOTT LABORATORIES : Correction to Abbott Labs Deals Story
12:10pDJAbbott Labs Reaches Deals for Transcatheter Mitral-Valve Developers
12:04p ASTRAZENECA : *s&p capital iq raises astrazeneca to 'buy' ('hold') - price targe..
More sector news : Biopharmaceuticals
News from SeekingAlpha
07/29 Cardiome Pharma inks $15M capital raise
07/26 WEEK IN REVIEW : 3SBio Acquires Wansheng Pharma For $85 Million
05/13 Cardiome Pharma's (CRME) CEO William Hunter on Q1 2015 Results - Earnings Cal..
05/13 Cardiome Pharma reports Q1 results
05/13 Cardiome Pharma beats by $0.07, misses on revenue


Comments 
Advertisement
Chart CARDIOME PHARMA CORP
Duration : Period :
Cardiome Pharma Corp Technical Analysis Chart | COM | CA14159U3010 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions